Dr. Soorani is experienced in Deep transcranial magnetic stimulation (DTMS therapy). He is the Medical Director of Westside Neurotherapeutics where he is conducting treatment and DTMS therapy. He creates customized treatment plans for patients with Major Depressive Disorder (MDD & others) when antidepressants have failed to produce a satisfactory outcome. This therapy stimulates the pre-frontal cortex.
Brainsway Deep TMS is a unique safe non-invasive and highly effective treatment. Deep TMS (Transcranial Magnetic Stimulation) activates deep brain regions which are responsible for depression, generating significant improvement for patients, including those who tried several cycles of antidepressants. Brainsway Deep TMS is a treatment that does not require any hospitalization or anesthesia, and does not entail any memory loss or systemic side effects. Deep TMS requires 20 brief daily sessions, 20 minutes each, over a period of four to five weeks.
In each session, the patient is seated comfortably in a chair, and a padded helmet is gently placed on the patient’s head. A unique patented coil within the helmet creates brief magnetic fields, similar to those used in Magnetic Resonance Imaging (MRI). The magnetic fields briefly stimulate the brain area. After each session, the patient returns home independently and resumes his/her daily routine.
Side Effects: Deep TMS has no relationship to ECT (Electroconvulsive Treatment). Deep TMS does not cause memory impairment, nor require a hospital setting, anesthesia, or restraints. The vast majority of patients tolerate each session without any difficulty.
Patients with most medical conditions are eligible for treatment. Certain conditions require individual evaluation.
- See more at: DTMSWestsideNeurotherapeutics
10850 Wilshire Blvd. Ste. #1270
Los Angeles, CA 90024
Phone: (310) 946-0008
or email for further information to: firstname.lastname@example.org.
**Blue Cross/Blue Shield and other carriers may reimburse partial payment for this treatment for Major Depressive Disorder (MDD). Patients will need prior authorization and the failure of two, consecutive SSRIs.
Westside Neurotherapeutics will assist patients with obtaining approval. Otherwise treatment is a cash payment.